Loading...
Although clinical trials have demonstrated the benefits of pharmacological treatment of alcohol and opioid use disorders, its effects on suicidal behavior and crime have not been studied in real-world situations. Using Swedish national registry data in 2005 through 2013, investigators studied all individuals treated for alcohol or opioid use disorder with acamprosate (n=10,309), naltrexone (n=4389), buprenorphine (with or without naloxone; n=3320), or methadone (n=5449).
In within-individual analyses, criminal arrests, accidental overdoses (resulting in death or treatment), and suicidal behaviors (resulting in death or treatment) were compared when participants were on versus off substance-use treatment. To reduce confounding, the researcher…